JLL vs XENE · P/E 23, rev $13.31B vs $2.55B cap
Jones Lang LaSalle Incorporated (JLL) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
JLL currently screens at market cap $12.12B and trailing P/E 23.0. XENE currently screens at market cap $2.55B.
Not investment advice. Open the JLL and XENE stock pages for the full models.
Not investment advice.